Glaxosmithkline Plc (GSK)

Ringing the Bell for a Ten-Fund Lineup Precidian Investments, the sponsor behind the ADRhedged™ platform, rang the opening bell at the New York Sto...

GSK plc (NYSE:GSK) has spent much of 2026 adding new drugs to its pipeline, and Berenberg is starting to think investors aren't giving it enough credit.

GSK plc (NYSE:GSK) is adding another cancer drug to a pipeline that has been getting considerably more attention under CEO Luke Miels.

On September 3, HUTCHMED (China) Limited (NASDAQ:HCM) announced an exclusive global development and licensing agreement with GSK plc (NYSE:GSK) for HMPL-A830, targeting colorectal, pancreatic, and lung...

Shares of Tempus AI ($TEM) jumped 15% Thursday, extending their five-day gain to nearly 40%. The rally came after CEO Eric Lefkofsky outlined the c...

GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at risk.

GSK plc (NYSE:GSK) is advancing its experimental seasonal influenza vaccine into late-stage development after encouraging mid-stage results in both younger and older adults.

GSK plc (NYSE:GSK) has reached two important regulatory milestones involving treatments for chronic hepatitis B and rectal cancer.

HUTCHMED stock soared on Thursday after the company announced a new licensing deal with GlaxoSmithKline.